Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels

Archives of Gynecology and Obstetrics

Volumn 286, Issue 1, 2012, Pages 147-153

  Kim, Hoon ^a   Ku, Seung Yup ^b,c   Suh, Chang Suk ^b,c   Kim, Seok Hyun ^b,c   Kim, Jong Hak ^d   Kim, Jung Gu ^b,c  

^a Department of Internal Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

DR; Endometriosis; OPG; Polymorphism; TRAIL

Indexed keywords

GENOMIC DNA; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENDOMETRIOSIS; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KOREAN; MAJOR CLINICAL STUDY; OSTEOPROTEGERIN GENE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND GENE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR GENE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; OSTEOPROTEGERIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REPUBLIC OF KOREA; TNF-RELATED APOPTOSIS-INDUCING LIGAND; YOUNG ADULT;

EID: 84864421337     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2263-0     Document Type: Article

References (25)

1. Mathur SP (2000) Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 44(2):89-95
2. Simpson JL, BischoV FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30(1):21-40 vii
3. Tempfer CB, Simoni M, Destenaves B, Fauser BC (2009) Functional genetic polymorphisms and female reproductive disorders: part II-endometriosis. Hum Reprod Update 15(1):97-118. doi:10.1093/humupd/dmn040
4. Garcia-Velasco JA, Arici A (2003) Apoptosis and the pathogene-sis of endometriosis. Semin Reprod Med 21(2):165-172. doi:10.1055/s-2003-41323
5. Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66(8):1403-1408
6. Bersinger NA, von Roten S, Wunder DM, Raio L, Dreher E, Mueller MD (2006) PAPP-A and osteoprotegerin, together with inter-leukin-8 and RANTES, are elevated in the peritoneal Xuid of women with endometriosis. Am J Obstet Gynecol 195(1):103-108. doi:10.1016/j.ajog.2005.12.010
7. Harada M, Osuga Y, Hirata T, Hirota Y, Koga K, Yoshino O, Mor-imoto C, Fujiwara T, Momoeda M, Yano T, Tsutsumi O, Taketani Y (2004) Concentration of osteoprotegerin (OPG) in peritoneal Xuid is increased in women with endometriosis. Hum Reprod 19(10):2188-2191. doi:10.1093/humrep/deh412
8. Wang SH, Cao Z, Wolf JM, Van Antwerp M, Baker JR Jr (2005) Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 146(11):4721-4726. doi:10.1210/en.2005- 0627
9. Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M (2005) Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis 64(6):854-858. doi:10.1136/ard. 2004.029058
10. Kim JG, Kim H, Ku SY, Kim SH, Choi YM, Moon SY (2004) Association between human alpha 2-Heremans Schmidt glycoprotein (AHSG) polymorphism and endometriosis in Korean women. Fertil Steril 82(6):1497-1500. doi:10.1016/j.fertnstert.2004.05.089
11. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY (2005) Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 20(10):2904-2908. doi:10.1093/humrep/dei146
12. Chae SJ, Kim H, Jee BC, Suh CS, Kim SH, Kim JG (2008) Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am J Reprod Immunol 60(5):432-439
13. Fernandez V, Jares P, Bea S, Salaverria I, Guino E, de Sanjose S, Colomer D, Ott G, Montserrat E, Campo E (2004) Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms. Haematologica 89(11):1322-1331
14. Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS (2001) Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7(6):1688-1697
15. Frank B, Shanmugam KS, Beckmann L, Hemminki K, Brenner H, HoVmeister M, Chang-Claude J, Burwinkel B (2006) Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomark Prev 15(10):2002-2005. doi:10.1158/1055-9965.EPI-06-0053
16. Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X (2003) Death receptor 4 and bladder cancer risk. Cancer Res 63(6):1157-1159
17. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, Miyazaki Y, Sasaki H (2005) TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 167(1-2):170-174. doi:10.1016/j.jneuroim.2005. 06.021
18. Yan X, Xu L, Qi J, Liang X, Ma C, Guo C, Zhang L, Sun W, Zhang J, Wei X, Gao L (2009) sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenet-ics 61(8):551-556. doi:10.1007/s00251-009- 0389-4
19. American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classiWcation of endometriosis: 1996. Fertil Steril 67(5):817-821
20. Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegerin gene are associated with osteo-porotic fractures. J Bone Miner Res 17(7):1245-1255. doi:10.1359/jbmr.2002.17.7.1245
21. Yamada Y, Ando F, Niino N, Shimokata H (2003) Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Mol Genet Metab 80(3):344-349. doi:10.1016/S1096-7192(03) 00125-2
22. Martinez-Ferrandis JI, Rodriguez-Lopez R, Milne RL, Gonzalez E, Cebolla E, Chirivella I, Zamora P, Arias JI, Palacios S, Cervantes A, Diez O, Benitez J, Armengod ME (2007) Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark 3(2):89-93
23. Horak P, Pils D, Roessler M, Tomek S, Elandt K, Zeillinger R, Zielinski C, Krainer M (2005) Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer. Gynecol Oncol 97(2):514-518. doi:10.1016/j.ygyno. 2005.01.021
24. Zhao HY, Liu JM, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL (2005) The inXuence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int 16(12):1519-1524. doi:10.1007/s00198-005-1865-9
25. Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA (2002) Investigation of the genetic inXu-ence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 71(1):26-35. doi:10.1007/s00223-001-2081-z